Cathay Biotech Inc Working Capital to Net Assets Ratio
Cathay Biotech Inc working capital to net assets ratio. Cathay Biotech Inc (688065) has a Working Capital to Net Assets ratio of 44.9% as of June 2026. Working capital of CN¥9.68 Billion (current assets of CN¥11.96 Billion minus current liabilities of CN¥2.28 Billion) is measured against net assets of CN¥21.59 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 688065 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Cathay Biotech Inc (2016–2025)
Working capital to net assets ratio of Cathay Biotech Inc from 2016 to 2025. This chart shows how Cathay Biotech Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 44.9%, reflecting working capital of CN¥9.68 Billion against net assets of CN¥21.59 Billion CNY. See Cathay Biotech Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Cathay Biotech Inc Working Capital to Net Assets Ratio by Year (2016–2025)
Cathay Biotech Inc working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Cathay Biotech Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Cathay Biotech Inc assets under control.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 21.6% | CN¥9.72 Billion | CN¥45.10 Billion | CN¥11.73 Billion | CN¥2.01 Billion | ▼ -8.0 pp |
| 2024 | 29.6% | CN¥4.47 Billion | CN¥15.10 Billion | CN¥7.39 Billion | CN¥2.92 Billion | ▲ +1.4 pp |
| 2023 | 28.2% | CN¥4.16 Billion | CN¥14.77 Billion | CN¥7.57 Billion | CN¥3.41 Billion | ▼ -18.7 pp |
| 2022 | 46.9% | CN¥7.05 Billion | CN¥15.04 Billion | CN¥8.48 Billion | CN¥1.42 Billion | ▼ -22.4 pp |
| 2021 | 69.3% | CN¥10.18 Billion | CN¥14.69 Billion | CN¥11.39 Billion | CN¥1.22 Billion | ▼ -0.5 pp |
| 2020 | 69.7% | CN¥8.01 Billion | CN¥11.48 Billion | CN¥8.44 Billion | CN¥434.77 Million | ▲ +33.8 pp |
| 2019 | 35.9% | CN¥1.67 Billion | CN¥4.64 Billion | CN¥2.71 Billion | CN¥1.04 Billion | ▲ +26.1 pp |
| 2018 | 9.8% | CN¥308.44 Million | CN¥3.16 Billion | CN¥1.82 Billion | CN¥1.51 Billion | ▲ +5.2 pp |
| 2017 | 4.6% | CN¥100.70 Million | CN¥2.20 Billion | CN¥898.92 Million | CN¥798.22 Million | ▼ -25.5 pp |
| 2016 | 30.1% | CN¥366.86 Million | CN¥1.22 Billion | CN¥791.81 Million | CN¥424.96 Million | — |